This early-phase trial tests a new drug called TTX-MC138 in 16 people with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and see if the drug can shrink or stabilize tumors. It is an open-label study, meaning everyone know…
Phase: PHASE1, PHASE2 • Sponsor: TransCode Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC